India-specific genome tests: The future of healthcare
Could public health in India be better served by genome testing tailored specifically to the Indian population? The answer could be yes. “Diagnostic techniques have been built and developed for the developed markets so obviously, the cost structure is accordingly,” argued Nikhil Jakatdar, chief executive officer (CEO) of GenePath Diagnostics in an interview with the …
India-specific genome tests: The future of healthcare Read More »